You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

163 Results
Guidelines and Advice
Status: Current
ID: GL 17-12
Version: N/A
Sep 2019
Document
Nov 2019
Document
Nov 2019
Document
Nov 2019
Document
Nov 2019
Document
Nov 2019
Document
Nov 2019
Document
Nov 2019
Regimen
Cancer Type:
Hematologic, 
Leukemia - Chronic Lymphocytic (CLL)
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Drugs Used:
iBRUtinib (Unfunded),
riTUXimab (Unfunded)
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Aug 2020
Document
Aug 2020
Statistical Reports
Oct 2020
Statistical Reports
Sep 2016

Pages